Open AccessInfluence of pharmorubicin on the left ventricular ejection fraction of patients with breast cancer: A mechanism study
Author(s) -
Hu Liu,
Ming-Rui Xie,
Haokao Gao,
Jian Li
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.202230
Subject(s) - ejection fraction , breast cancer , medicine , cardiac function curve , cancer , cardiology , flow cytometry , heart failure , immunology
Breast cancer is a great public health problem. It remains unclear how pharmorubicin induces cardiac dysfunction in patients with breast cancer. Our study was aimed to explore the influence of pharmorubicin on the left ventricular ejection fraction (EF) of patients with breast cancer and its potential mechanism.